Pulmonology. 2018 Dec;24 Suppl 1:1-21. doi: 10.1016/j.pulmoe.2018.09.004.
Portuguese consensus document for the management of alpha-1-antitrypsin deficiency.
Lopes AP1, Mineiro MA2, Costa F3, Gomes J4, Santos C5, Antunes C5, Maia D2, Melo R6, Canotilho M7, Magalhães E8, Vicente I8, Valente C9, Gonçalves BG10, Conde B11, Guimarães C12, Sousa C13, Amado J14, Brandão ME11, Sucena M13, Oliveira MJ15, Seixas S16, Teixeira V17, Telo L5.
Abstract
Alpha-1-antitrypsin deficiency (AATD) is a genetic autosomal codominant disorder caused by mutations in SERPINA1 gene. It is one of the most prevalent genetic disorders, although it remains underdiagnosed. Whereas at international level there are several areas of consensus on this disorder, in Portugal, inter-hospital heterogeneity in clinical practice and resources available have been adding difficulties in reaching a diagnosis and in making therapeutic decisions in this group of patients. This raised a need to draft a document expressing a national consensus for AATD. To this end, a group of experts in this field was created within the Portuguese Pulmonology Society - Study group on AATD, in order to elaborate the current manuscript. The authors reviewed the existing literature and provide here general guidance and extensive recommendations for the diagnosis and management of AATD that can be adopted by Portuguese clinicians from different areas of Medicine. This article is part of a supplement entitled "Portuguese consensus document for the management of alpha-1-antitrypsin deficiency" which is sponsored by Sociedade Portuguesa de Pneumologia.
KEYWORDS:
Alpha 1-Antitrypsin Deficiency; Consensus; Diagnosis; Pulmonary Emphysema; Therapeutics
- PMID:
- 30473034
- DOI:
- 10.1016/j.pulmoe.2018.09.004
Free full text
No hay comentarios:
Publicar un comentario